There has been very interesting research at MIT done to suggest that actually scientists or physicians, I'm sorry, physicians working with patients for whom no treatments are available have been historically very powerful source of innovation, possibly the most powerful source of innovation in the pharmaceutical industry over the decades because they know the disease, they know the patients, they know a little bit about pharmacology, and they were trying to customize treatments for those patients using drugs that were approved for something else. It's kind of Darwinian (?) experimentation that's repeated millions of times every day across the land, and when you have that sort of thing going on, by luck or by design, some of that thing is going to work, and we see it in every disease. So if you have patients that are alert, and if you network them and allow them to share the clinical insight, especially the clinical observations that are unexpected, I don't think it will be long before someone notices, “Gee, you know, I had this patient and she had disease XYZ and I gave her that drug and the CFS got better or disappeared.” There have been instances of that happening already, so we need to harvest that sort of creativity.